• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

广谱细菌素加维菌素Q的溶液结构

Solution Structure of the Broad-Spectrum Bacteriocin Garvicin Q.

作者信息

Mallett Tyler, Lamer Tess, Aleksandrzak-Piekarczyk Tamara, McKay Ryan T, Catenza Karizza, Sit Clarissa, Rainey Jan K, Towle-Straub Kaitlyn M, Vederas John C, van Belkum Marco J

机构信息

Department of Chemistry, University of Alberta, Edmonton, AB T6G 2G2, Canada.

Institute of Biochemistry and Biophysics, Polish Academy of Sciences, 02-106 Warsaw, Poland.

出版信息

Int J Mol Sci. 2025 Aug 14;26(16):7846. doi: 10.3390/ijms26167846.

DOI:10.3390/ijms26167846
PMID:40869166
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12386314/
Abstract

Class IId bacteriocins are linear, unmodified antimicrobial peptides produced by Gram-positive bacteria, and often display potent, narrow-spectrum inhibition spectra. Garvicin Q (GarQ) is a class IId bacteriocin produced by the lactic acid bacterium . It stands out for its unusual broad-spectrum antimicrobial activity against various bacterial species, including , , , , and spp. Its protein target is the mannose phosphotransferase system (Man-PTS) of susceptible bacterial strains, though little is known about the precise molecular mechanism behind GarQ's unusual broad spectrum of activity. In this work, C- and N-labelled GarQ was recombinantly produced using our previously described "sandwiched" protein expression system in . We also developed a protocol to purify a uniformly labelled sample of the small ubiquitin-like modifier His-SUMO, which is produced as a byproduct of the expression procedure. We demonstrated its use as a "free" protein standard for 3D NMR experiment calibrations. The GarQ solution structure was solved using triple-resonance nuclear magnetic resonance (NMR) spectroscopy and was compared with the structures of other Man-PTS-targeting bacteriocins. GarQ adopts a helix-hinge-helix fold, which is contrary to its structural predictions according to AlphaFold 3.

摘要

II类细菌素是由革兰氏阳性菌产生的线性、未修饰的抗菌肽,通常表现出强大的窄谱抑制谱。加维菌素Q(GarQ)是一种由乳酸菌产生的II类细菌素。它以其对包括[具体细菌种类1]、[具体细菌种类2]、[具体细菌种类3]、[具体细菌种类4]和[具体细菌种类5]等多种细菌的异常广谱抗菌活性而脱颖而出。其蛋白质靶点是敏感细菌菌株的甘露糖磷酸转移酶系统(Man-PTS),尽管对于GarQ异常广谱活性背后的确切分子机制知之甚少。在这项工作中,使用我们之前描述的“夹心”蛋白质表达系统在[具体表达宿主]中重组生产了C和N标记的GarQ。我们还开发了一种方案来纯化作为表达过程副产物产生的小泛素样修饰物His-SUMO的均匀标记样品。我们展示了其作为3D NMR实验校准的“游离”蛋白质标准品的用途。使用三重共振核磁共振(NMR)光谱解析了GarQ溶液结构,并与其他靶向Man-PTS的细菌素结构进行了比较。GarQ采用螺旋-铰链-螺旋折叠,这与其根据AlphaFold 3的结构预测相反。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d2/12386314/8d226e2879a2/ijms-26-07846-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d2/12386314/3f5f5b99c355/ijms-26-07846-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d2/12386314/385c619c56d9/ijms-26-07846-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d2/12386314/5e73eb08790b/ijms-26-07846-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d2/12386314/95b98e589d83/ijms-26-07846-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d2/12386314/8d226e2879a2/ijms-26-07846-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d2/12386314/3f5f5b99c355/ijms-26-07846-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d2/12386314/385c619c56d9/ijms-26-07846-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d2/12386314/5e73eb08790b/ijms-26-07846-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d2/12386314/95b98e589d83/ijms-26-07846-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d2/12386314/8d226e2879a2/ijms-26-07846-g005.jpg

相似文献

1
Solution Structure of the Broad-Spectrum Bacteriocin Garvicin Q.广谱细菌素加维菌素Q的溶液结构
Int J Mol Sci. 2025 Aug 14;26(16):7846. doi: 10.3390/ijms26167846.
2
The Non-Lantibiotic Bacteriocin Garvicin Q Targets Man-PTS in a Broad Spectrum of Sensitive Bacterial Genera.非兰抗生素细菌素 Garvicin Q 靶向多种敏感细菌属中的 Man-PTS。
Sci Rep. 2017 Aug 21;7(1):8359. doi: 10.1038/s41598-017-09102-7.
3
BacSJ-Another Bacteriocin with Distinct Spectrum of Activity that Targets Man-PTS.巴戟天素 SJ-另一种具有独特作用谱的细菌素,作用靶点为人 PTS。
Int J Mol Sci. 2020 Oct 23;21(21):7860. doi: 10.3390/ijms21217860.
4
The extracellular loop of Man-PTS subunit IID is responsible for the sensitivity of Lactococcus garvieae to garvicins A, B and C.Man-PTS 亚基 IID 的细胞外环负责乳球菌对 garvicin A、B 和 C 的敏感性。
Sci Rep. 2018 Oct 25;8(1):15790. doi: 10.1038/s41598-018-34087-2.
5
Novel Group of Leaderless Multipeptide Bacteriocins from Gram-Positive Bacteria.革兰氏阳性菌中新型无 leader 多肽细菌素组
Appl Environ Microbiol. 2016 Aug 15;82(17):5216-24. doi: 10.1128/AEM.01094-16. Print 2016 Sep 1.
6
Toward safer and sustainable food preservation: a comprehensive review of bacteriocins in the food industry.迈向更安全、可持续的食品保鲜:食品工业中细菌素的全面综述
Biosci Rep. 2025 Apr 17;45(4):BSR20241594. doi: 10.1042/BSR20241594.
7
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
8
A core human gut microbe, , produces a broad-spectrum bacteriocin mediterrocin.一种核心人类肠道微生物,[具体微生物名称缺失],产生一种广谱细菌素——地中海菌素。
mBio. 2025 Jul 17:e0152325. doi: 10.1128/mbio.01523-25.
9
Identification and characterization of a circular bacteriocin, garvicin SC, a novel garvicin ML variant, produced by Lactococcus garvieae ABG0038.加氏乳球菌ABG0038产生的环状细菌素加维菌素SC(一种新型加维菌素ML变体)的鉴定与表征。
J Biosci Bioeng. 2025 Feb;139(2):95-99. doi: 10.1016/j.jbiosc.2024.10.008. Epub 2024 Nov 19.
10
An antibiotic-free antimicrobial combination of bacteriocins and a peptidoglycan hydrolase: and assessment of its efficacy.一种不含抗生素的细菌素与肽聚糖水解酶的抗菌组合及其疗效评估。
Appl Environ Microbiol. 2025 Jun 24:e0243324. doi: 10.1128/aem.02433-24.

本文引用的文献

1
Critical Assessment of RNA and DNA Structure Predictions via Artificial Intelligence: The Imitation Game.通过人工智能对RNA和DNA结构预测的批判性评估:模仿游戏。
J Chem Inf Model. 2025 Apr 14;65(7):3544-3554. doi: 10.1021/acs.jcim.5c00245. Epub 2025 Mar 30.
2
UniProt: the Universal Protein Knowledgebase in 2025.通用蛋白质知识库(UniProt):2025年的情况
Nucleic Acids Res. 2025 Jan 6;53(D1):D609-D617. doi: 10.1093/nar/gkae1010.
3
Subclass IId bacteriocins targeting mannose phosphotransferase system-Structural diversity and implications for receptor interaction and antimicrobial activity.
靶向甘露糖磷酸转移酶系统的IId类细菌素——结构多样性及其对受体相互作用和抗菌活性的影响
PNAS Nexus. 2024 Sep 3;3(9):pgae381. doi: 10.1093/pnasnexus/pgae381. eCollection 2024 Sep.
4
RCSB protein Data Bank: exploring protein 3D similarities via comprehensive structural alignments.RCSB 蛋白质数据库:通过全面的结构比对探索蛋白质 3D 相似性。
Bioinformatics. 2024 Jun 3;40(6). doi: 10.1093/bioinformatics/btae370.
5
Accurate structure prediction of biomolecular interactions with AlphaFold 3.利用 AlphaFold 3 进行生物分子相互作用的精确结构预测。
Nature. 2024 Jun;630(8016):493-500. doi: 10.1038/s41586-024-07487-w. Epub 2024 May 8.
6
mutants resistant to lactococcin A and garvicin Q reveal missense mutations in the sugar transport domain of the mannose phosphotransferase system.对乳球菌素 A 和戊糖素 Q 具有抗性的突变体显示出磷酸甘露糖转移酶系统糖转运结构域中的错义突变。
Microbiol Spectr. 2024 Jan 11;12(1):e0313023. doi: 10.1128/spectrum.03130-23. Epub 2023 Dec 4.
7
Balancing the risks and benefits of antibiotic use in a globalized world: the ethics of antimicrobial resistance.在全球化世界中平衡抗生素使用的风险和益处:抗微生物药物耐药性的伦理问题。
Global Health. 2023 Apr 20;19(1):27. doi: 10.1186/s12992-023-00930-z.
8
Simplified cloning and isolation of peptides from "sandwiched" SUMO-peptide-intein fusion proteins.从“夹心法”SUMO-肽-内含肽融合蛋白中简化肽的克隆和分离。
BMC Biotechnol. 2023 Apr 5;23(1):11. doi: 10.1186/s12896-023-00779-5.
9
Structural Basis of the Mechanisms of Action and Immunity of Lactococcin A, a Class IId Bacteriocin.乳球菌素 A 的作用机制和免疫机制的结构基础,一种 IId 类细菌素。
Appl Environ Microbiol. 2023 Mar 29;89(3):e0006623. doi: 10.1128/aem.00066-23. Epub 2023 Feb 22.
10
Garvicin Q: characterization of biosynthesis and mode of action.Garvicin Q:生物合成与作用模式的特征。
Microb Cell Fact. 2022 Nov 11;21(1):236. doi: 10.1186/s12934-022-01952-9.